Palladia is a drug owned by ZOETIS INC. It is protected by 3 US drug patents filed from 2020 to 2027. Out of these, 1 patent is active and 2 patents have expired. Details of Palladia’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US7211600 | 22 Dec, 2020 | Expired |
About Palladia
Palladia is a drug
owned by ZOETIS INC.
Palladia uses
Toceranib Phosphate as the active
ingredient.
Active Ingredient:
Palladia uses
Toceranib Phosphate as the active ingredient.
Check out other Drugs and Companies using
Toceranib Phosphate ingredient.